The Senior Director of Strategic Accounts will serve as a key member of the REM and RO Leadership Team, be a critical contributor to the development and execution of SERBs holistic US Access strategy and will partner closely with Sales, Marketing, Value Access and Trade verticals (Corporate Accounts, Payer/Reimbursement, Trade), Medical Affairs, Commercial Development, Commercial Operations, and other cross-functional stakeholders to deliver business results while fostering a culture of collaboration, accountability, agility, and continuous improvement. This individual must possess deep experience in acute care hospital markets, including the successful commercialization of injectable therapies, and have a proven ability to influence key Healthcare Decision Makers (HCDMs) across IDNs including pharmacy, surgery, anaesthesia, emergency medicine, critical care, oncology and executive leadership.